PROTAC repurposing uncovers a noncanonical binding surface that mediates chemical degradation of nuclear receptors
Proteolysis-targeting chimeras (PROTACs) containing a target protein ligand linked to an E3 ubiquitin ligase ligand induce target protein degradation through E3 recruitment. Most PROTACs bind a surface cleft of the protein of interest rather than a buried pocket. Using the nuclear receptor PXR, we previously described the inherent difficulties of PROTAC targeting via a deep solvent-inaccessible ligand binding pocket. Here, we discover that the CRBN-dependent MDM2 PROTAC MD-224 is a potent PXR degrader that achieves its activity from binding adjacent to the ligand-binding pocket. Furthermore, because the proximal region is a structural feature common among nuclear receptors, MD-224 also targets additional receptors for proteasomal degradation. Using structure- and activity-guided medicinal chemistry, we ablated MDM2 degradation and generated MD-224 analogs with activities skewed toward different receptors. Thus, we describe (1) PROTAC repurposing as a potential route of degrader discovery and (2) nuclear receptor-targeted degradation through a noncanonical binding site.
Authors
- Andrew D. Huber (ORCID: https://orcid.org/0000-0002-3790-8368)
- Taosheng Chen (ORCID: https://orcid.org/0000-0001-6420-3809)
- Junmin Peng (ORCID: https://orcid.org/0000-0003-0472-7648)
- Jingheng Wang (ORCID: https://orcid.org/0009-0007-2859-4882)
- Yingxue Fu (ORCID: https://orcid.org/0000-0003-3052-4131)
- Shondra M. Pruett‐Miller (ORCID: https://orcid.org/0000-0002-3793-585X)
- Shyaron Poudel (ORCID: https://orcid.org/0000-0002-4819-0929)
- Vishwajeeth Pagala (ORCID: https://orcid.org/0000-0002-9110-5232)
- Stephanie D. Byrum (ORCID: https://orcid.org/0000-0002-1783-3610)
- Elizabeth D. Arnold (ORCID: https://orcid.org/0009-0000-8916-667X)
- Allister J. Loughran (ORCID: https://orcid.org/0000-0002-6564-5526)
- Ka Yang (ORCID: https://orcid.org/0000-0001-8937-7397)
- Zuo‐Fei Yuan (ORCID: https://orcid.org/0000-0003-1252-6766)
- Wenwei Lin (ORCID: https://orcid.org/0000-0001-8754-6150)
- Allison Carrigan (ORCID: https://orcid.org/0009-0006-6588-1429)
- Rebecca R. Florke Gee (ORCID: https://orcid.org/0000-0002-4736-3154)
- Wei Wang (ORCID: https://orcid.org/0000-0002-6346-2216)
- Guangwei Yang
- Jing Wu
- Kwan‐Young Jung (ORCID: https://orcid.org/0000-0002-5631-8814)
Institutions
- St. Jude Children's Research Hospital (US)
Publication Details
- Journal
- Nature Communications
- Published
- 2025-11-06
- DOI
- https://doi.org/10.1038/s41467-025-64773-5
- Citations
- 1
- Primary Topic
- Protein Degradation and Inhibitors
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- University of Pittsburgh
- American Lebanese Syrian Associated Charities
- National Institutes of Health
- National Cancer Institute
- National Institute of General Medical Sciences